In particular, a reversed and statistically significant (at the 5% level) gender test score gap is observed in favour of male students in third grade reading, where male students outperform female students by about 0.07 standard deviations.
In 2014, a comparison of doxorubicin alone versus the combination with ifosfamide (in the randomised phase III EORTC 62012) showed no difference in overall survival (OS), but a difference in response and progression-free survival (PFS) were observed in favour of the combination but at the expense of increased toxicity.
In the latter group, only a trend (not significant) of greater response rate was observed in favour of baseline Hb >13 g dl−1.
Only after 40 days of cold stress, noticeable change in relative abundance of isoforms was observed in favour of PsbO2 [ 22].
No trends observed in favour of our hypothesis reached statistical significance and should be regarded as interesting observations worthy of further investigation.
A large survival benefit of 12.0 months was observed in favour of simultaneous chemoradiation irrespective of whether conventionally fractionated, hyperfractionated or accelerated radiation schedules were used.
A survival benefit of 14.2 months (95% CI: 10.2 to 18.5 months) was observed in favour of HFRT (p < 0.001, figure 6, table 4).
A numerical difference for moderate and severe peripheral oedemas was also observed in favour of lumiracoxib, although it did not reach statistical significance.
At a median follow-up of 6.7 years, a 19% reduction in the hazard of death was observed in favour of the FEC14 arm.
In addition, significant differences in the average daily time spent in euglycaemia (3.9 10 mmol/l) and hyperglycaemia (>10 mmol/l) were observed in favour of the Sensor On arm (Table 2).
In our previous study with one hundred and eighteen persons with fibromyalgia, significant differences in treatment outcome across the three Multidimensional Pain Inventory subgroups were mainly observed in favour of the dysfunctional subgroup [ 23].
